Award
National Human Genome Research Institute 5R44HG014445-02
Developing a New Nucleic Acid Extraction Technology to Enable High Quality DNA Sequencing for Formalin Fixed Paraffin Embedded Tissue Samples
Recipient
VELLUM BIOTECHNOLOGY, INC.
Award Amount
$1,014,715.00
Ceiling
$1,014,715.00
Awarded
June 16, 2026
Identifier
5R44HG014445-02
Award to VELLUM BIOTECHNOLOGY, INC. to develop a new nucleic acid extraction technology for improved DNA sequencing of formalin fixed paraffin embedded tissue samples using epitachophoresis technology.
Description
The project aims to develop epitachophoresis (ETP) technology employing a circular well and liquid/liquid interface to improve nucleic acid purification, yielding higher quantities, better quality, and faster processing times. It builds on preliminary studies demonstrating superior yields and sequencing quality compared to commercial systems from Promega and Qiagen.